Position in ABBV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$228,328,825
+$153,038,790 QoQ
Shares Held
907,363
+162.1% QoQ
Ownership
0.051%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#142
of 4,153 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $1,229,733,122 across 9 Drug Manufacturers - General names. ABBV ranks #3 (18.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
244,861 | $293,693,653 | |
| 2 | JNJ |
Johnson & Johnson
|
1,050,526 | $266,802,088 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
907,363 | $228,328,825 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,124,149 | $144,453,146 | |
| 5 | AMGN |
Amgen Inc
|
238,092 | $86,217,875 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,167,476 | $67,269,967 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
528,600 | $66,783,324 | |
| 8 | PFE |
Pfizer Inc
|
2,154,713 | $51,885,489 |
All Filings in ABBV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,328,825 | 907,363 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $75,290,035 | 346,177 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,844,361 | 196,264 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $54,055,559 | 233,461 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $61,133,761 | 329,349 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $131,598,254 | 628,094 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $107,518,806 | 605,058 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $159,709,185 | 808,736 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $128,695,229 | 750,322 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $116,251,365 | 638,393 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $197,539,794 | 1,274,697 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $185,333,154 | 1,243,346 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $56,701,794 | 420,855 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $76,498,396 | 480,005 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $72,655,654 | 449,574 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,109,080 | 187,088 | Shares | Sole | 2022-11-14 | |
| 2021-12-31 | $144,905,215 | 1,070,201 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $84,182,718 | 780,409 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $68,770,099 | 610,530 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $15,284,451 | 141,235 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||